Reports for NALOXONE HCL INJECTION - 0.4MG/ML USP
Brand name
NALOXONE HCL INJECTION - 0.4MG/ML USP
Company Name
SANDOZ CANADA INCORPORATED
|
Drug Identification Number
02148706 |
Ingredients
NALOXONE HYDROCHLORIDE |
Ingredient Strength
0.4 MG |
ATC Code
V03AB |
ATC Descriptor
ALL OTHER THERAPEUTIC PRODUCTS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| NALOXONE HCL INJECTION - 0.4MG/ML USP | 10 X 1ML AMPOULES | Avoided shortage | 2017-03-21 | 2017-06-26 | 3823 |
| NALOXONE HCL INJECTION - 0.4MG/ML USP | 10ML 1LIVI | Resolved | 2022-03-10 | 2022-04-06 | 156432 |
| NALOXONE HCL INJECTION - 0.4MG/ML USP | 10ML VIAL | Resolved | 2017-03-21 | 2017-04-12 | 3820 |
| NALOXONE HCL INJECTION - 0.4MG/ML USP | 1X10ml | Resolved | 2019-04-05 | 2019-07-08 | 80570 |
Showing 1 to 4 of 4
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0